This statistic shows the leukemia patients survival rates before and after introduction of drug Imatinib, over a period of five years. The survival rate has increased drastically from 31 percent up to 89 percent.
Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PhRMA. (April 30, 2015). Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)* [Graph]. In Statista. Retrieved November 19, 2024, from https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/
PhRMA. "Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*." Chart. April 30, 2015. Statista. Accessed November 19, 2024. https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/
PhRMA. (2015). Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)*. Statista. Statista Inc.. Accessed: November 19, 2024. https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/
PhRMA. "Survival Rates of Leukemia Patients Prior and after Introduction of Imatinib (as of 2015)*." Statista, Statista Inc., 30 Apr 2015, https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/
PhRMA, Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)* Statista, https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/ (last visited November 19, 2024)
Survival rates of leukemia patients prior and after introduction of Imatinib (as of 2015)* [Graph], PhRMA, April 30, 2015. [Online]. Available: https://www.statista.com/statistics/478985/leukemia-drug-treatment-survival-rates-imatinib/
